Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $11,724 | 6 | 61.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,115 | 1 | 21.5% |
| Consulting Fee | $2,904 | 3 | 15.2% |
| Food and Beverage | $401.26 | 3 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma Inc | $15,747 | 7 | $0 (2023) |
| SANOFI US SERVICES INC. | $2,279 | 2 | $0 (2018) |
| Janssen Research & Development, LLC | $625.00 | 1 | $0 (2021) |
| GENZYME CORPORATION | $493.98 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $15,747 | 7 | Astellas Pharma Inc ($15,747) |
| 2021 | $625.00 | 1 | Janssen Research & Development, LLC ($625.00) |
| 2019 | $286.63 | 2 | GENZYME CORPORATION ($286.63) |
| 2018 | $1,509 | 2 | SANOFI US SERVICES INC. ($1,302) |
| 2017 | $976.50 | 1 | SANOFI US SERVICES INC. ($976.50) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/15/2023 | Astellas Pharma Inc | Xtandi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,115.00 | General |
| Category: Oncology | ||||||
| 01/17/2023 | Astellas Pharma Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $190.00 | General |
| Category: Oncology | ||||||
| 01/14/2023 | Astellas Pharma Inc | Xtandi (Drug) | Travel and Lodging | In-kind items and services | $270.35 | General |
| Category: Oncology | ||||||
| 01/14/2023 | Astellas Pharma Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $67.07 | General |
| Category: Oncology | ||||||
| 01/13/2023 | Astellas Pharma Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $10,577.83 | General |
| Category: Oncology | ||||||
| 01/13/2023 | Astellas Pharma Inc | Xtandi (Drug) | Travel and Lodging | In-kind items and services | $270.35 | General |
| Category: Oncology | ||||||
| 01/13/2023 | Astellas Pharma Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $255.94 | General |
| Category: Oncology | ||||||
| 11/08/2021 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $159.79 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $126.84 | General |
| 10/26/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $207.35 | General |
| 04/10/2018 | SANOFI US SERVICES INC. | NO PRODUCT DISCUSSED (Drug) | Consulting Fee | Cash or cash equivalent | $1,302.00 | General |
| 01/01/2017 | SANOFI US SERVICES INC. | NO PRODUCT DISCUSSED (Drug) | Consulting Fee | Cash or cash equivalent | $976.50 | General |
About Steven Balk
Steven Balk is a Hematology & Oncology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1497884779.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Steven Balk has received a total of $19,144 in payments from pharmaceutical and medical device companies, with $15,747 received in 2023. These payments were reported across 13 transactions from 4 companies. The most common payment nature is "Travel and Lodging" ($11,724).
Practice Information
- Specialty Hematology & Oncology
- Location Boston, MA
- Active Since 03/05/2007
- Last Updated 07/08/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1497884779
Products in Payments
- Xtandi (Drug) $15,747
- NO PRODUCT DISCUSSED (Drug) $2,772
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Boston
Dr. Julio Hajdenberg, Md, MD
Hematology & Oncology — Payments: $1.1M
Dr. Eric Jacobsen, Md, MD
Hematology & Oncology — Payments: $1.1M
Paul Richardson, Md, MD
Hematology & Oncology — Payments: $920,265
Matthew Davids, M.d, M.D
Hematology & Oncology — Payments: $808,362
David Avigan, M.d, M.D
Hematology & Oncology — Payments: $679,225
Anthony Letai, Md, MD
Hematology & Oncology — Payments: $569,795